Broken drug markets in infectious diseases: Opportunities outside the private sector?

Open Access

Viewpoints are opinion pieces grounded in evidence on topics of broad interest to the journal's readership.

Jonathan D. Alpern ,

* E-mail: Jonathan.D.Alpern@HealthPartners.com (JDA); stauf055@umn.edu (WMS)

Affiliations Division of Infectious Diseases, Department of Medicine, HealthPartners, Minneapolis, Minnesota, United States of America, HealthPartners Institute, Minneapolis, Minnesota, United States of America

http://orcid.org/0000-0001-8514-8693

⨯
Stephen J. Dunlop,

Affiliation Department of Emergency Medicine, Hennepin County Medical Center, Minneapolis, Minnesota, United States of America
⨯
William M. Stauffer

* E-mail: Jonathan.D.Alpern@HealthPartners.com (JDA); stauf055@umn.edu (WMS)

Affiliations Division of Infectious Diseases, Department of Medicine, HealthPartners, Minneapolis, Minnesota, United States of America, Department of Medicine, University of Minnesota-Minneapolis, Minnesota, United States of America
⨯

Reader Comments (0)

Drug prices
Is the Subject Area "Drug prices" applicable to this article?

Thanks for your feedback.
Drug administration
Is the Subject Area "Drug administration" applicable to this article?

Thanks for your feedback.
Vaccines
Is the Subject Area "Vaccines" applicable to this article?

Thanks for your feedback.
Malaria
Is the Subject Area "Malaria" applicable to this article?

Thanks for your feedback.
Antimalarials
Is the Subject Area "Antimalarials" applicable to this article?

Thanks for your feedback.
Sulfates
Is the Subject Area "Sulfates" applicable to this article?

Thanks for your feedback.
Artesunate
Is the Subject Area "Artesunate" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.